BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

EYEMATE-SC Biosensor for Remote Glaucoma Care is CE Marked

The patented EYEMATE system is the world’s only clinically-validated product used for comprehensive remote glaucoma monitoring. US FDA Breakthrough D...

June 21, 2021 | News

Oxygen saturation level in covid-19, the forerunner of crisis

As per norms. If the oxygen saturation is 94% or lower, the patient needs immediate attention. Saturation of less than 90% is a clinical emergency. Pulse-O...

June 21, 2021 | Opinion

Merck to Accelerate Progress towards Improved Birth Outcomes for All

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today the creation of the Kenneth C. Frazier Award for Maternal Health Equi...

June 21, 2021 | News

deCODE genetics: Predicting the probability of death

In a paper published today in Communications Biology, scientists from deCODE genetics, a subsidiary of Amgen, describe how they developed pr...

June 21, 2021 | News

New Cleveland Clinic Research Identifies Link Between Gut Microbes and Stroke

New findings from Cleveland Clinic researchers show for the first time that the gut microbiome impacts stroke severity and functional impairment ...

June 17, 2021 | News

How Does “No Mask Required” Affect Air Quality and Risk Mitigation Strategies

Can owners and managers of local businesses and workplaces breathe a sigh of relief that they don’t need to worry about Severe Acute Respiratory Synd...

June 16, 2021 | Opinion | By Behind The Bench Staff | ThermoFisher

FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns

Thermal burns are typically caused by direct contact with an external heat source such as steam, scalding water, hot surfaces or fire. "Serious burns can ...

June 16, 2021 | News

AAS : Next Steps For New Alzheimer's Treatment

Additionally, the FDA appropriately took into account the vast unmet need of the Alzheimer's community. Aduhelm is certainly not a cure, but at long last i...

June 14, 2021 | News

Viraleze registered for sale in Covid-ravaged India

The announcement came as the world's second most populous country battles a devastating second wave of COVID-19 infections, with over 29 million cases and ...

June 14, 2021 | News

Japan takes step ahead to treat hereditary deafness

Researchers at Juntendo University in Japan report in the journal Human Molecular Genetics that a stem-cell technique may be used to develop a tr...

June 11, 2021 | News

VinBrain and FIT Utilizing AI in Tuberculosis Screening in Veitnam

Tuberculosis is the leading cause of deaths worldwide from an infectious disease, second only to COVID-19. Vietnam ranks 11th among t...

June 10, 2021 | News

FDA’s Decision to Approve New Treatment for Alzheimer’s Disease

This approval is significant in many ways. Aduhelm is the first novel therapy approved for Alzheimer’s disease since 2003. Perhaps more significantly...

June 09, 2021 | News | By Dr. Patrizia Cavazzoni, Director, FDA Center for Drug Evaluation and Research

“700,000 people in USA are living with primary brain tumour”

Brain tumors originate from the brain itself, or it can be secondary extension from other parts. Brain tumors in India comes to 5-10 in 100,000 popul...

June 08, 2021 | Opinion

Cigna Study Shows Uncertainty about the Future Continues to be the Leading Cause of Stress

Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's an...

June 08, 2021 | Analysis

Stay Connected